Mark your calendars for Tuesday 5th November 2024, as Bioventus (NASDAQ: BVS) is set to unveil its third quarter financial results. This highly anticipated announcement will be made before market open, giving investors and market participants a chance to assess the company's financial performance.
In accordance with the predictions of financial analysts on Wall Street, the firm is on track to report an expected per share of $0.03 profit for the quarter. Furthermore, the firm is projected to disclose a total revenue of $133.23 million for this quarter.
When looking back at the corresponding quarter from the previous year, the company's earnings report showcased a per-share income of $0.05. This was attributed to the company's total revenue, which amounted to an impressive $120.79 million during that same period.
The company's yearly performance has been analyzed by Wall Street analysts, who have projected a total revenue of $561.77 million. Additionally, they are expecting the company to achieve a per share profit of $0.39 for the fiscal year 2024.
In addition, The firm will review the third quarter financial results on 5th November 2024 at 08:30 AM eastern time, in a conference call with public.
Bioventus (BVS) closed Friday's regular trading session at $13.58, demonstrating a 0.07 percent gain, with a volume of 330.00 thousand shares.
